LifeStance Health: UBS Reiterates Buy Rating, Raises PT to $10 from $9.

viernes, 7 de noviembre de 2025, 11:31 am ET1 min de lectura
LFST--

LifeStance Health: UBS Reiterates Buy Rating, Raises PT to $10 from $9.

LifeStance Health: UBS Reiterates Buy Rating, Raises PT to $10 from $9.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios